AGM Notes, page-29

Yep, crazy market. SPL is one of the most undervalued stocks going, no doubt about it. I know things take time in the Pharma space, but this is ridiculous. People want all the guarantees. At present the share price only reflects fleurstat imo, not even the entire VivaGel portfolio, and definitely not DEP. Until the market wakes up to the full potential I guess we have to be patient. But it seems ridiculous to me that something like CPH could overtake SPL last week on not much more than hot air, and then break for another CR. At these levels I'm rejigging my super to buy more SPL, especially after the AGM. Opportunities like this don't come around very often.